Skip to main content
. 2019 Mar 14;9:4519. doi: 10.1038/s41598-019-41200-6

Table 3.

Proportion of participants that reported moderate, mild or no discomfort on the SSQ.

SSQ item Moderate Mild No
HMD-VR Control HMD-VR Control HMD-VR Control
General discomfort 0.00 0.05 0.11 0.16 0.89 0.79
Fatigue 0.05 0.11 0.08 0.13 0.87 0.76
Headache 0.00 0.00 0.05 0.09 0.95 0.92
Eye strain 0.05 0.08 0.16 0.09 0.78 0.82
Difficulty focusing 0.00 0.08 0.19 0.09 0.81 0.82
Increase of salivation 0.00 0.03 0.05 0.00 0.95 0.97
Sweating 0.03 0.03 0.16 0.03 0.81 0.92
Nausea 0.00 0.00 0.03 0.03 0.97 0.97
Difficulty concentrating 0.03 0.08 0.08 0.16 0.89 0.74
Fullness of the head 0.03 0.13 0.14 0.08 0.84 0.76
Blurred vision 0.03 0.08 0.08 0.08 0.89 0.84
Dizziness with eyes open 0.00 0.00 0.03 0.03 0.97 0.97
Dizziness with eyes closed 0.00 0.05 0.00 0.03 1.00 0.92
Vertigo 0.00 0.03 0.00 0.05 1.00 0.92
Stomach awareness 0.00 0.00 0.00 0.05 1.00 0.95
Burping 0.00 0.00 0.03 0.03 0.97 0.97

Values represent the proportion of participants who rated each SSQ item as moderate, mild or no discomfort. Ratings of severe discomfort on the SSQ items are not included in the table as they did not occur in the HMD-VR group.